Terns Pharmaceuticals IncNASDAQ:TERN
- LAST PRICE5.7900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots5.7400/ 10
- Ask / Lots5.8600/ 9
- Open / Previous Close5.9500 / 5.7900
- Day Range
- 52 Week Range
- Volume1,032,968
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TERN |
|---|---|---|
| 09:32 ET | 15652 | 5.925 |
| 09:33 ET | 2536 | 5.946 |
| 09:35 ET | 996 | 5.96 |
| 09:37 ET | 250 | 5.96 |
| 09:39 ET | 11649 | 5.91 |
| 09:42 ET | 1174 | 5.942 |
| 09:44 ET | 1232 | 5.94 |
| 09:46 ET | 1891 | 5.93 |
| 09:48 ET | 100 | 5.93 |
| 09:50 ET | 5599 | 5.9134 |
| 09:51 ET | 930 | 5.9 |
| 09:53 ET | 5400 | 5.88 |
| 09:55 ET | 1058 | 5.84 |
| 09:57 ET | 11699 | 5.87 |
| 10:00 ET | 1150 | 5.87 |
| 10:02 ET | 1367 | 5.84 |
| 10:04 ET | 2400 | 5.86 |
| 10:06 ET | 4553 | 5.83 |
| 10:08 ET | 3056 | 5.84 |
| 10:09 ET | 4812 | 5.8 |
| 10:11 ET | 3000 | 5.78 |
| 10:13 ET | 9516 | 5.73 |
| 10:15 ET | 9758 | 5.73 |
| 10:18 ET | 3919 | 5.775 |
| 10:20 ET | 1618 | 5.79 |
| 10:22 ET | 2160 | 5.775 |
| 10:24 ET | 2000 | 5.77 |
| 10:26 ET | 2500 | 5.78 |
| 10:27 ET | 13541 | 5.8 |
| 10:29 ET | 6198 | 5.775 |
| 10:31 ET | 1741 | 5.79 |
| 10:33 ET | 740 | 5.805 |
| 10:36 ET | 3877 | 5.83 |
| 10:38 ET | 3655 | 5.82 |
| 10:40 ET | 1900 | 5.845 |
| 10:42 ET | 1000 | 5.845 |
| 10:44 ET | 600 | 5.8273 |
| 10:45 ET | 6100 | 5.815 |
| 10:47 ET | 2196 | 5.82 |
| 10:49 ET | 24817 | 5.87 |
| 10:51 ET | 5901 | 5.86 |
| 10:54 ET | 1200 | 5.86 |
| 10:56 ET | 1438 | 5.86 |
| 10:58 ET | 3702 | 5.87 |
| 11:00 ET | 1000 | 5.865 |
| 11:02 ET | 1500 | 5.85 |
| 11:03 ET | 1000 | 5.84 |
| 11:05 ET | 600 | 5.84 |
| 11:07 ET | 8382 | 5.835 |
| 11:09 ET | 2025 | 5.825 |
| 11:12 ET | 12600 | 5.82 |
| 11:14 ET | 10520 | 5.85 |
| 11:16 ET | 2250 | 5.855 |
| 11:18 ET | 30288 | 5.895 |
| 11:20 ET | 4020 | 5.915 |
| 11:21 ET | 500 | 5.9129 |
| 11:23 ET | 1909 | 5.87 |
| 11:25 ET | 5940 | 5.88 |
| 11:27 ET | 1300 | 5.87 |
| 11:30 ET | 500 | 5.865 |
| 11:32 ET | 2200 | 5.865 |
| 11:34 ET | 3508 | 5.8811 |
| 11:36 ET | 3540 | 5.91 |
| 11:38 ET | 1400 | 5.9 |
| 11:39 ET | 2610 | 5.875 |
| 11:41 ET | 600 | 5.875 |
| 11:43 ET | 12968 | 5.9 |
| 11:45 ET | 2676 | 5.88 |
| 11:48 ET | 555 | 5.88 |
| 11:50 ET | 1100 | 5.88 |
| 11:52 ET | 1900 | 5.885 |
| 11:54 ET | 3136 | 5.915 |
| 11:56 ET | 1750 | 5.9 |
| 11:57 ET | 3922 | 5.92 |
| 11:59 ET | 2484 | 5.935 |
| 12:01 ET | 1798 | 5.94 |
| 12:03 ET | 3100 | 5.94 |
| 12:06 ET | 3798 | 5.935 |
| 12:08 ET | 300 | 5.935 |
| 12:10 ET | 1480 | 5.9234 |
| 12:12 ET | 400 | 5.925 |
| 12:14 ET | 1229 | 5.89 |
| 12:15 ET | 9575 | 5.87 |
| 12:17 ET | 1263 | 5.87 |
| 12:19 ET | 815 | 5.865 |
| 12:21 ET | 1562 | 5.84 |
| 12:24 ET | 300 | 5.83 |
| 12:26 ET | 1222 | 5.82 |
| 12:28 ET | 3306 | 5.815 |
| 12:30 ET | 174 | 5.81 |
| 12:32 ET | 9173 | 5.81 |
| 12:33 ET | 2156 | 5.82 |
| 12:35 ET | 917 | 5.83 |
| 12:37 ET | 700 | 5.835 |
| 12:39 ET | 514 | 5.835 |
| 12:42 ET | 1027 | 5.855 |
| 12:44 ET | 500 | 5.855 |
| 12:46 ET | 2140 | 5.845 |
| 12:48 ET | 1870 | 5.84 |
| 12:50 ET | 3152 | 5.845 |
| 12:51 ET | 700 | 5.845 |
| 12:53 ET | 2000 | 5.855 |
| 12:55 ET | 500 | 5.855 |
| 12:57 ET | 2950 | 5.865 |
| 01:00 ET | 610 | 5.875 |
| 01:02 ET | 1000 | 5.875 |
| 01:04 ET | 2200 | 5.89 |
| 01:06 ET | 1306 | 5.885 |
| 01:08 ET | 3300 | 5.9021 |
| 01:09 ET | 900 | 5.89 |
| 01:11 ET | 1300 | 5.895 |
| 01:13 ET | 2077 | 5.89 |
| 01:15 ET | 700 | 5.895 |
| 01:18 ET | 900 | 5.885 |
| 01:20 ET | 410 | 5.87 |
| 01:22 ET | 1900 | 5.875 |
| 01:24 ET | 700 | 5.865 |
| 01:26 ET | 1200 | 5.86 |
| 01:27 ET | 1248 | 5.865 |
| 01:29 ET | 1165 | 5.875 |
| 01:31 ET | 1907 | 5.885 |
| 01:33 ET | 1200 | 5.905 |
| 01:36 ET | 1090 | 5.91 |
| 01:38 ET | 1900 | 5.9 |
| 01:40 ET | 600 | 5.9 |
| 01:42 ET | 1100 | 5.9 |
| 01:44 ET | 600 | 5.9 |
| 01:45 ET | 1625 | 5.885 |
| 01:47 ET | 5400 | 5.91 |
| 01:49 ET | 700 | 5.89 |
| 01:51 ET | 1091 | 5.86 |
| 01:54 ET | 1300 | 5.855 |
| 01:56 ET | 748 | 5.8599 |
| 01:58 ET | 410 | 5.855 |
| 02:00 ET | 620 | 5.855 |
| 02:02 ET | 1630 | 5.845 |
| 02:03 ET | 1573 | 5.855 |
| 02:05 ET | 2598 | 5.865 |
| 02:07 ET | 1369 | 5.865 |
| 02:09 ET | 2508 | 5.87 |
| 02:12 ET | 600 | 5.875 |
| 02:14 ET | 1500 | 5.89 |
| 02:16 ET | 700 | 5.885 |
| 02:18 ET | 2908 | 5.875 |
| 02:20 ET | 630 | 5.86 |
| 02:21 ET | 780 | 5.86 |
| 02:23 ET | 500 | 5.845 |
| 02:25 ET | 1500 | 5.845 |
| 02:27 ET | 1700 | 5.845 |
| 02:30 ET | 630 | 5.845 |
| 02:32 ET | 1240 | 5.845 |
| 02:34 ET | 2427 | 5.835 |
| 02:36 ET | 3873 | 5.825 |
| 02:38 ET | 3480 | 5.845 |
| 02:39 ET | 810 | 5.84 |
| 02:41 ET | 1000 | 5.84 |
| 02:43 ET | 1350 | 5.84 |
| 02:45 ET | 1775 | 5.85 |
| 02:48 ET | 1456 | 5.86 |
| 02:50 ET | 1618 | 5.85 |
| 02:52 ET | 1186 | 5.845 |
| 02:54 ET | 2271 | 5.855 |
| 02:56 ET | 1200 | 5.85 |
| 02:57 ET | 800 | 5.845 |
| 02:59 ET | 400 | 5.845 |
| 03:01 ET | 2689 | 5.84 |
| 03:03 ET | 927 | 5.84 |
| 03:06 ET | 2550 | 5.805 |
| 03:08 ET | 4315 | 5.81 |
| 03:10 ET | 2150 | 5.81 |
| 03:12 ET | 2255 | 5.835 |
| 03:14 ET | 1164 | 5.82 |
| 03:15 ET | 1000 | 5.82 |
| 03:17 ET | 3016 | 5.825 |
| 03:19 ET | 2276 | 5.815 |
| 03:21 ET | 531 | 5.805 |
| 03:24 ET | 14720 | 5.805 |
| 03:26 ET | 700 | 5.805 |
| 03:28 ET | 1889 | 5.8 |
| 03:30 ET | 1058 | 5.7869 |
| 03:32 ET | 6440 | 5.81 |
| 03:33 ET | 1509 | 5.845 |
| 03:35 ET | 3778 | 5.845 |
| 03:37 ET | 4350 | 5.845 |
| 03:39 ET | 4259 | 5.835 |
| 03:42 ET | 3541 | 5.845 |
| 03:44 ET | 3939 | 5.835 |
| 03:46 ET | 7417 | 5.835 |
| 03:48 ET | 7958 | 5.835 |
| 03:50 ET | 2903 | 5.825 |
| 03:51 ET | 7006 | 5.825 |
| 03:53 ET | 10528 | 5.835 |
| 03:55 ET | 16818 | 5.83 |
| 03:57 ET | 22050 | 5.8 |
| 04:00 ET | 177179 | 5.79 |
Nov 18, 2024
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors, from 4:05PM ET on Monday Nov 18, 2024 by Dow Jones
4:05PM ET on Monday Nov 18, 2024 by Dow JonesPress Release: Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors, from 4:05PM ET on Monday Nov 18, 2024 by Dow Jones
4:05PM ET on Monday Nov 18, 2024 by Dow Jones
Nov 13, 2024
DJ Terns Pharmaceuticals Is Maintained at Neutral by HC Wainwright & Co., from 2:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
2:01PM ET on Wednesday Nov 13, 2024 by Dow Jones
Nov 12, 2024
Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow JonesPress Release: Terns Pharmaceuticals Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Terns Pharmaceuticals Inc | 488.7M | -4.9x | --- |
Celcuity Inc | 488.4M | -5.3x | --- |
ProKidney Corp | 489.6M | -3.3x | --- |
Korro Bio Inc | 486.4M | -3.1x | --- |
Opthea Ltd | 484.9M | -1.1x | --- |
GH Research PLC | 482.3M | 0.0x | --- |
Company Information
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Its pipeline includes three clinical-stage development programs: TERN-701, TERN-601 and TERN-501. TERN-701 is its oral, potent, allosteric BCR-ABL tyrosine kinase inhibitors (TKI) specifically targeting the ABL myristoyl pocket for CML, a form of cancer that begins in the bone marrow and leads to the growth of leukemic cells. TERN-601 is a small-molecule glucagon-like peptide-1 receptor (GLP-1R) agonist that is intended to be orally administered for obesity and other metabolic diseases. TERN-501 is a thyroid hormone receptor beta (THR-b) agonist with high metabolic stability and liver distribution. It is also focused on developing the TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity.
Contact Information
- Headquarters
- 1065 East Hillsdale Blvd. Suite 100, Suite 100FOSTER CITY, CA, United States 94404
- Phone
- 650-525-5535
- Fax
- 650-275-4395
Executives
- Independent Chairman of the Board
- David Fellows
- Chief Executive Officer, Director
- Amy Burroughs
- Chief Financial Officer, Treasurer
- Mark Vignola
- Chief Development Officer
- Scott Harris
- Chief Business Officer
- Sun Jung
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $488.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 84.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.39 |
EPS | $-1.18 |
Book Value | $3.95 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
